Catalyst Wire Dossier Catalyst Wire Dossier

Chemotherapy treatment of physician's choice

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chemotherapy treatment of physician's choice, covering 2020-08-10 to 2020-08-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation [Phase 3]

See pricing